(Reuters) – Johnson & Johnson said on Friday that its single-dose vaccine was 66% effective at stopping COVID-19 in a large global trial against several variants, giving health officials another weapon to …
Read More »Privacy activist files complaint against Apple’s tracking tool
BERLIN (Reuters) – On Monday, a group led by privacy activist Max Schrems filed complaints with Apple against German and Spanish data officials. AAPL.O Online tracking tool, alleging that it allows iPhones …
Read More »Asian stocks hit record highs due to vaccine virus fears
SYDNEY (Reuters) – Asian stocks reached a record high on Monday as vaccine optimism and strong economic data from China and Japan expressed concern about rising cases of coronovirus, picking up about …
Read More »Biden dollar fell to two-month low after US presidency
SYDNEY (Reuters) – The dollar hit a 10-week low on Monday, as investors chose Jude Biden’s election as US president to buy trade-expected currencies on an expected basis, leading to a White …
Read More »Q & A: Where are we in the race for the COVID-19 vaccine?
NEW YORK (Reuters) – Drugmakers and research centers around the world are working on the COVID-19 vaccine, which includes large global trials of several candidates in which thousands of participants are participating …
Read More »Biden gains shares and bonds as inches toward victory
By Mark Jones, Wayne Cole LONDON / SYDNEY (Reuters) – Stock markets in Europe and Asia gained momentum and bonds pushed up their rally on Thursday as Democrat Joe Biden was close …
Read More »T-cell study adds COVID-19 to debate immune period
LONDON (Reuters) – A small but important UK study found that “cellular immunity” to the pandemic SARS-CoV-2 virus is present after six months in people who have mild or asymptomatic COVID-19. Was, …
Read More »Cognitive cost of COVID? Some patients may have a brain age of 10 years
LONDON (Reuters) – People recovering from COVID-19 may face the effects of significant brain function, with the worst cases of infection associated with mental decline equivalent to brain aging of up to …
Read More »Lockdown Anxiety Drugs Shares Rapidly Low; The dollar rises
NEW YORK (Reuters) – Stocks sank around the world on Wednesday as concerns over rising COVID-19 cases in Europe, the United States, and elsewhere, while the US dollar secured increased economic demand. …
Read More »Apple supplier exposes LuxShares Foxconn as US-China’s feudal speed supply chain shift
Yimu Lee by Josh Horwitz TAIPEI / Shanghai (Reuters) – Apple AAPL.O Top iPhone assembler, Taiwan-based Foxconn, has formed a task force to curb the growing dominance of Chinese electronics manufacturer LuxShare, …
Read More »